Cargando…
A tricyclic antidepressant, amoxapine, reduces amyloid-β generation through multiple serotonin receptor 6-mediated targets
Alzheimer’s disease (AD) is a major and devastating neurodegenerative disease, and the amyloid-β (Aβ) hypothesis is still the central theory for AD pathogenesis. Meanwhile, another major mental illness, depression, is one of the risk factors for AD. From a high-throughput screening (HTS), amoxapine,...
Autores principales: | Li, Xiaohang, Wang, Qinying, Hu, Tingting, Wang, Ying, Zhao, Jian, Lu, Jing, Pei, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504036/ https://www.ncbi.nlm.nih.gov/pubmed/28694424 http://dx.doi.org/10.1038/s41598-017-04144-3 |
Ejemplares similares
-
Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant
por: Wilson, Tyler J., et al.
Publicado: (2018) -
Do the binding sites of substrates and tricyclic antidepressants overlap on the serotonin transporter?
por: Sarker, Subhodeep, et al.
Publicado: (2008) -
Amoxapine-induced tardive dyskinesia
por: Singh, Gurvinder Pal
Publicado: (2009) -
The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter
por: Sarker, Subhodeep, et al.
Publicado: (2010) -
Chronic Pain Treatment: The Influence of Tricyclic Antidepressants on Serotonin Release and Uptake in Mast Cells
por: Ferjan, Ilonka, et al.
Publicado: (2013)